The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The FDA classified LifeVac as a Class II medical device
Subscribe To Our Newsletter & Stay Updated
